10-QPeriod: Q2 FY2002

AGILENT TECHNOLOGIES, INC. Quarterly Report for Q2 Ended Apr 30, 2002

Filed June 5, 2002For Securities:A

Summary

Agilent Technologies, Inc.'s 10-Q filing for the period ending April 30, 2002, presents a mixed financial picture for investors. The company is navigating a challenging economic environment, with results reflecting both growth in certain segments and overall pressure on sales. Investors should pay close attention to the detailed breakdown of revenue by segment and the management's discussion on financial condition and results of operations for a deeper understanding of the underlying business dynamics and future outlook. The filing provides unaudited condensed consolidated financial statements, including the statement of earnings, balance sheet, and cash flows. While specific figures for net earnings or revenue growth are not provided in the excerpt, the emphasis on "Management's Discussion and Analysis" suggests that the company is providing context and commentary on its performance, highlighting factors influencing its financial condition and operational results. Investors are encouraged to review these sections thoroughly to assess the company's strategic responses to market conditions and its prospects for the remainder of the fiscal year.

Key Highlights

  • 1The filing contains unaudited condensed consolidated financial statements for the three and six months ended April 30, 2002, and comparative periods.
  • 2Key financial statements include the Statement of Earnings, Balance Sheet, and Statement of Cash Flows.
  • 3Management's Discussion and Analysis of Financial Condition and Results of Operations is a core section for investors to understand performance drivers.
  • 4Disclosures regarding Market Risk provide insights into how Agilent manages potential financial exposures.
  • 5The report details Legal Proceedings, which could represent potential financial liabilities or strategic risks.
  • 6The filing includes Exhibits and Reports on Form 8-K, which may contain material events or disclosures not covered elsewhere.

Frequently Asked Questions

The provided excerpt focuses on the structure and content of the 10-Q filing. To assess Agilent's overall financial health, investors need to review the detailed financial statements (Statement of Earnings, Balance Sheet, Statement of Cash Flows) and the 'Management's Discussion and Analysis' section within the full report for specific figures on revenue, profitability, debt, and cash flow, as well as management's commentary on these trends.

The excerpt does not specify the revenue-generating segments of Agilent Technologies. Investors should refer to the 'Management's Discussion and Analysis' section, which typically breaks down revenue by business segment, providing insights into the performance of different parts of the company.

The filing includes a section on 'Quantitative and Qualitative Disclosures about Market Risk,' which outlines the company's exposure to various market risks such as interest rate, foreign currency, and equity price risks, and how it manages these. Additionally, the 'Legal Proceedings' section could highlight any significant ongoing legal matters that pose a risk to the company.